Download FREE Report Sample
Download Free sampleAmphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.
Amphotericin B Market contains market size and forecasts of Amphotericin B in Global, including the following market information:
Global Amphotericin B Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Amphotericin B market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Static Drops Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amphotericin B include Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma and Astellas Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amphotericin B companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amphotericin B Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Amphotericin B Market Segment Percentages, by Type, 2021 (%)
Static Drops
Atomization Inhalation
Local Lesion Injection
Other
Global Amphotericin B Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Amphotericin B Market Segment Percentages, by Application, 2021 (%)
Vaginitis
Candida Infection
Leishmaniasis
Kala-Azar
Cryptococcal Infection
Aspergillus Infection
Other
Global Amphotericin B Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Amphotericin B Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amphotericin B revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Amphotericin B revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Matinas BioPharma
Nanox
Nanomerics
DNDi
Abzena
Bharat Serums
Jina Pharma
Astellas Pharma
Leadiant Biosciences
Kadmon Corporation (Eli Lilly and Company)
InterMune
Sterimax Inc
X-GEN Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy